FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310022012> ?p ?o ?g. }

• W4310022012 endingPage "1202" @default.
• W4310022012 startingPage "1191" @default.
• W4310022012 abstract "Interleukin-1 receptor accessory protein (IL-1RAP) is one of the most promising therapeutic targets proposed for myeloid leukemia. Antibodies (Abs) specific to IL-1RAP could be valuable tools for targeted therapy of this lethal malignancy. This study is about the preparation of a difficult-to-produce single-chain variable fragment (scFv) construct against the membrane-bound isoform of human IL-1RAP using Escherichia coli (E. coli). Different approaches were examined for refolding and characterization of the scFv. Binding activities of antibody fragments were comparatively evaluated using cell-based enzyme-linked immunosorbent assay (ELISA). Homogeneity and secondary structure of selected scFv preparation were analyzed using analytical size exclusion chromatography (SEC) and circular dichroism (CD) spectroscopy, respectively. The activity of the selected preparation was evaluated after long-term storage, repeated freeze-thaw cycles, or following incubation with normal and leukemic serum. Strategies for soluble expression of the scFv failed. Even with the help of Trx, ≥ 98% of proteins were expressed as inclusion bodies (IBs). Among three different refolding methods, the highest recovery rate was obtained from the dilution method (11.2%). Trx-tag substantially enhanced the expression level (18%, considering the molecular weight (MW) differences), recovery rate (˃1.6-fold), and binding activity (˃2.6-fold increase in absorbance450nm). The produced scFv exhibited expected secondary structure as well as acceptable bio-functionality, homogeneity, and stability. We were able to produce 21 mg/L culture functional and stable anti-IL-1RAP scFv via recovering IBs by pulse dilution procedure. The produced scFv as a useful targeting agent could be used in scheming new therapeutics or diagnostics for myeloid malignancies." @default.
• W4310022012 created "2022-11-30" @default.
• W4310022012 creator A5023526131 @default.
• W4310022012 creator A5027990453 @default.
• W4310022012 creator A5028326676 @default.
• W4310022012 creator A5046928819 @default.
• W4310022012 creator A5055354356 @default.
• W4310022012 creator A5057546392 @default.
• W4310022012 creator A5067474502 @default.
• W4310022012 creator A5069597228 @default.
• W4310022012 creator A5070160944 @default.
• W4310022012 creator A5073944805 @default.
• W4310022012 creator A5080550711 @default.
• W4310022012 creator A5088377096 @default.
• W4310022012 date "2022-11-26" @default.
• W4310022012 modified "2023-10-15" @default.
• W4310022012 title "Bacterial production and biophysical characterization of a hard-to-fold scFv against myeloid leukemia cell surface marker, IL-1RAP" @default.
• W4310022012 cites W1915464687 @default.
• W4310022012 cites W1981398391 @default.
• W4310022012 cites W1987134040 @default.
• W4310022012 cites W2006211137 @default.
• W4310022012 cites W2006572288 @default.
• W4310022012 cites W2018502894 @default.
• W4310022012 cites W2022228265 @default.
• W4310022012 cites W2022964898 @default.
• W4310022012 cites W2027839322 @default.
• W4310022012 cites W2043876754 @default.
• W4310022012 cites W2045205653 @default.
• W4310022012 cites W2050184823 @default.
• W4310022012 cites W2055049815 @default.
• W4310022012 cites W2068305325 @default.
• W4310022012 cites W2073265895 @default.
• W4310022012 cites W2074726906 @default.
• W4310022012 cites W2076980393 @default.
• W4310022012 cites W2115764350 @default.
• W4310022012 cites W2133425057 @default.
• W4310022012 cites W2142529984 @default.
• W4310022012 cites W2150510929 @default.
• W4310022012 cites W2157873167 @default.
• W4310022012 cites W2163222586 @default.
• W4310022012 cites W2901703442 @default.
• W4310022012 cites W2942855506 @default.
• W4310022012 cites W2944271242 @default.
• W4310022012 cites W3047346221 @default.
• W4310022012 cites W3081485773 @default.
• W4310022012 cites W3090061815 @default.
• W4310022012 cites W3124832172 @default.
• W4310022012 cites W3185073486 @default.
• W4310022012 cites W3196777720 @default.
• W4310022012 doi "https://doi.org/10.1007/s11033-022-07972-3" @default.
• W4310022012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36435922" @default.
• W4310022012 hasPublicationYear "2022" @default.
• W4310022012 type Work @default.
• W4310022012 citedByCount "1" @default.
• W4310022012 countsByYear W43100220122023 @default.
• W4310022012 crossrefType "journal-article" @default.
• W4310022012 hasAuthorship W4310022012A5023526131 @default.
• W4310022012 hasAuthorship W4310022012A5027990453 @default.
• W4310022012 hasAuthorship W4310022012A5028326676 @default.
• W4310022012 hasAuthorship W4310022012A5046928819 @default.
• W4310022012 hasAuthorship W4310022012A5055354356 @default.
• W4310022012 hasAuthorship W4310022012A5057546392 @default.
• W4310022012 hasAuthorship W4310022012A5067474502 @default.
• W4310022012 hasAuthorship W4310022012A5069597228 @default.
• W4310022012 hasAuthorship W4310022012A5070160944 @default.
• W4310022012 hasAuthorship W4310022012A5073944805 @default.
• W4310022012 hasAuthorship W4310022012A5080550711 @default.
• W4310022012 hasAuthorship W4310022012A5088377096 @default.
• W4310022012 hasBestOaLocation W43100220122 @default.
• W4310022012 hasConcept C104317684 @default.
• W4310022012 hasConcept C1491633281 @default.
• W4310022012 hasConcept C153911025 @default.
• W4310022012 hasConcept C159654299 @default.
• W4310022012 hasConcept C185592680 @default.
• W4310022012 hasConcept C203014093 @default.
• W4310022012 hasConcept C2778729363 @default.
• W4310022012 hasConcept C40767141 @default.
• W4310022012 hasConcept C547475151 @default.
• W4310022012 hasConcept C55493867 @default.
• W4310022012 hasConcept C86803240 @default.
• W4310022012 hasConceptScore W4310022012C104317684 @default.
• W4310022012 hasConceptScore W4310022012C1491633281 @default.
• W4310022012 hasConceptScore W4310022012C153911025 @default.
• W4310022012 hasConceptScore W4310022012C159654299 @default.
• W4310022012 hasConceptScore W4310022012C185592680 @default.
• W4310022012 hasConceptScore W4310022012C203014093 @default.
• W4310022012 hasConceptScore W4310022012C2778729363 @default.
• W4310022012 hasConceptScore W4310022012C40767141 @default.
• W4310022012 hasConceptScore W4310022012C547475151 @default.
• W4310022012 hasConceptScore W4310022012C55493867 @default.
• W4310022012 hasConceptScore W4310022012C86803240 @default.
• W4310022012 hasFunder F4320322243 @default.
• W4310022012 hasFunder F4320326567 @default.
• W4310022012 hasIssue "2" @default.
• W4310022012 hasLocation W43100220121 @default.
• W4310022012 hasLocation W43100220122 @default.
• W4310022012 hasLocation W43100220123 @default.
• W4310022012 hasOpenAccess W4310022012 @default.

• next